Major changes in the 2024 ESC guidelines on chronic coronary syndromes

Prof. Andreotti presents on the major changes in the 2024 ESC guidelines on chronic coronary syndromes

Valve-in-Valve indications and challenges

Prof. Enrico Ferrari presents on the valve-in-valve indications and challenges.

Five years Survival of Patients Treated with Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) Compared with the General Swiss Population

Five years Survival of Patients Treated with Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) Compared with the General Swiss Population

Five years Survival of Patients Treated with Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) Compared with the General Swiss Population

Five years Survival of Patients Treated with Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) Compared with the General Swiss Population Part II

Reconsidering current approaches to valve and LVAD therapies

Edwards Lifesciences live-in-a box - Aortic valve replacement with minimally invasive approach, with the EDWARDS INTUITY Elite Valve System:

Prof. Günther Laufer

Edwards Lifesciences - Mastering EDWARDS INTUITY Elite Valve System: Surgeon's Journey and Expert Tips

Prof. Günther Laufer